Patient on ticagrelor one month after PCI with new onset atrial fibrillation - Panel discussion and questions from the audience.

28 August 2017 (15:05 - 15:20)

Organised by:

Video

Sign in for access options

7 More presentations in this session

Presentation thumbnail

Tailored antiplatelet therapy in PCI - Introduction to the session

Doctor L. Mauri (Boston, US)

Presentation thumbnail

Patient with a bleeding complication three weeks after DES implantation.

Professor P. Kala (Brno, CZ)

Presentation thumbnail

Patient with a bleeding complication three weeks after DES implantation - Panel discussion and questions from the audience.

Presentation thumbnail

Patient with bioresorbable scaffold thrombosis: 13 months after PCI.

Professor A. Avezum (Sao Paulo, BR)

Presentation thumbnail

Patient with bioresorbable scaffold thrombosis: 13 months after PCI - Panel discussion and questions from the audience.

Access the full session

Session thumbnail

Tailored antiplatelet therapy in PCI

The Event

ESC Congress 2017

28 August 2017 15:05 CET

You may be interested in

Congress Presentation

Atrial fibrillation in patients with acute coronary syndrome under clopidogrel versus ticagrelor.

13 March 2021

Congress Session

Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more

28 August 2023

Congress Presentation

Time investments and questions raised by atrial fibrillation patients following a personalized educational follow-up strategy

29 August 2022

Congress Presentation

Time to new-onset atrial fibrillation after transaortic valve implantation using 14-days ambulatory electrocardiographic monitoring

30 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources